Jennifer Doudna: How CRISPR lets us edit our DNA
Dženifer Daudna (Jennifer Doudna): Kako nam CRISPR omogućava da menjamo DNK
Jennifer Doudna was part of inventing a potentially world-changing genetic technology: the gene editing technology CRISPR-Cas9. Full bio
Double-click the English transcript below to play the video.
za preuređenje genoma.
for editing genomes.
scientists to make changes
da prave promene
to cure genetic disease.
da izlečimo genetske bolesti.
through a basic research project
iz jednog jednostavnog istraživanja
how bacteria fight viral infections.
kako se bakterije bore protiv virusa.
in their environment,
moraju da se susreću sa virusima
like a ticking time bomb --
kao tempirane bombe -
to defuse the bomb
da deaktivira bombu
an adaptive immune system called CRISPR,
image adaptivni imuni sistem, CRISPR,
viral DNA and destroy it.
da otkriju i unište virusnu DNK.
is a protein called Cas9,
pod nazivom Cas9,
and eventually degrade viral DNA
i na kraju degradira virusnu DNK
of this protein, Cas9,
aktivnost ovog proteina, Cas9,
harness its function
da iskoristimo njegovu funkciju
specific bits of DNA into cells
ili ubace određene delove DNK u ćelije
been possible in the past.
nisu bile moguće u prošlosti.
has already been used
of mice and monkeys,
u ćelijama miševa i majmuna,
the CRISPR technology
u ljudskim embrionima.
they could use CRISPR
da mogu da koriste CRISPR
of an integrated HIV virus
of genome editing
preuređuje genom
that we have to consider,
koja moramo da razmotrimo,
not only in adult cells,
ne samo na odraslim ćelijama,
about the technology that I co-invented,
o ovoj tehnologiji čiji sam su-osnivač,
and societal implications
sve etičke i društvene implikacije
what the CRISPR technology is,
šta je CRISPR tehnologija,
a prudent path forward
mudro da postupamo
ovu tehnologiju primenjujemo.
they inject their DNA.
oni ubace svoju DNK.
to be plucked out of the virus,
da se DNK iznese iz virusa
into the chromosome --
get inserted at a site called CRISPR.
umeću se na mestu pod nazivom CRISPR.
interspaced short palindromic repeats.
kratka palindromska ponavljanja.
zašto koristimo akronim CRISPR.
we use the acronym CRISPR.
to record, over time,
da tokom vremena beleže
are passed on to the cells' progeny,
se prenose na potomke tih ćelija,
not only in one generation,
ne samo u jednoj generaciji,
to keep a record of infection,
Blake Wiedenheft, likes to say,
voli da kaže,
a genetic vaccination card in cells.
karta vakcine u ćeliji.
into the bacterial chromosome,
u bakterijski hromozom,
of a molecule called RNA,
molekula zvanog RNK,
of the viral DNA.
with DNA molecules
from the CRISPR locus
to protein called Cas9,
like a sentinel in the cell.
funkcioniše kao stražar.
of the DNA in the cell,
the sequences in the bound RNAs.
sa sekvencama vezane RNK.
the blue molecule is DNA --
plavi molekul je DNK -
to cut up the viral DNA.
ispreseca virusnu DNK.
sentinel complex
možemo da posmatramo
that can cut DNA --
in the DNA helix.
this complex is programmable,
moguće programirati,
particular DNA sequences,
could be harnessed for genome engineering,
da se iskoristi za genetski inženjering,
a very precise change to the DNA
vrlo precizne promene u DNK
this break was introduced.
a word-processing program
programe za obradu teksta
u nekom dokumentu.
the CRISPR system for genome engineering
CRISPR-a za genetski inženjering
to detect broken DNA
da otkriju i poprave
a double-stranded break in its DNA,
dvostrani prekid u svojoj DNK,
the ends of the broken DNA
in the sequence of that position,
u sekvenci te pozicije,
a new piece of DNA at the site of the cut.
na mestu oštećenja.
double-stranded breaks into DNA
dvostrane prekide u DNK
to repair those breaks,
da poprave ta oštećenja,
of new genetic information.
nove genetske informacije.
the CRISPR technology
CRISPR tehnologiju
causing cystic fibrosis, for example,
koja uzrokuje cističnu fibrozu, recimo,
to repair that mutation.
da poprave tu mutaciju.
razvija se od 1970-ih.
it's been in development since the 1970s.
were very promising,
that they were either inefficient,
for use in their own laboratories,
u svom radu u laboratorijama,
clinical applications.
like CRISPR and utilize it has appeal,
genome engineering technologies
to rewire your computer
sa ponovnim instaliranjem računara
a new piece of software,
da pokrenete novi program,
is like software for the genome,
using these little bits of RNA.
koristeći ove male delove RNK.
break is made in DNA,
dvostrani presek u DNK,
astounding things,
izuzetne stvari,
that cause sickle cell anemia
koje uzrokuju anemiju ćelija
applications of the CRISPR technology
prvo upotrebljavati na krvi,
to deliver this tool into cells,
that's going on
of human disease, such as mice.
ljudskih bolesti, npr. miševima.
very precise changes
da se naprave vrlo precizne promene
na koji one u ćelijskoj DNK
that these changes in the cell's DNA
in this case, an entire organism.
na ceo organizam.
je korišćena da poremeti gen
was used to disrupt a gene
for the black coat color of these mice.
za crnu boju ovih miševa.
differ from their pigmented litter-mates
razlikuju od svojih obojenih rođaka
in the entire genome,
u celom genomu,
from these animals,
where we induced it,
gde smo je uveli
are going on in other animals
na drugim životinjama,
for human disease,
ljudskih bolesti,
that we can use these systems
da koristimo ove sisteme
in particular tissues,
na određenim tkivima,
kako da dostavimo CRISPR u ćelije.
the CRISPR tool into cells.
na koji se DNK popravlja posle oštećenja,
that DNA is repaired after it's cut,
and limit any kind of off-target,
i ograničimo bilo kakvo odstupanje
ove tehnologije.
of using the technology.
clinical application of this technology,
ove tehnologije,
da ćemo u tom vremenskom okviru
that we will see clinical trials
therapies within that time,
i možda odobrene terapije,
to think about.
around this technology,
u vezi sa ovom tehnologijom,
su veoma zainteresovane
in start-up companies
to commercialize the CRISPR technology,
CRISPR tehnologije,
in these companies.
for things like enhancement.
da se koristi za npr. poboljšanja.
to engineer humans
such as stronger bones,
kao što su jače kosti,
to cardiovascular disease
to be desirable,
ili visina, takve stvari.
or to be taller, things like that.
would give rise to these traits
bi podstakle ove osobine
to make such changes,
da takve promene pravimo,
that we have to carefully consider,
koja pažljivo moramo da razmotrimo
have called for a global pause
pozvali na globalnu pauzu
of the CRISPR technology in human embryos,
ove tehnologije na ljudskim embrionima,
implications of doing so.
implikacije toga.
precedent for such a pause
za takvu pauzu iz 1970-ih
on the use of molecular cloning,
u korišćenju molekularnog kloniranja,
could be tested carefully and validated.
nije bila pažljivo testirana i potvrđena.
are not with us yet,
još uvek nisu među nama,
are happening right now.
se upravo dešavaju.
a huge responsibility,
ogromnu odgovornost,
neželjene posledice,
both the unintended consequences
of a scientific breakthrough.
nekog naučnog otkrića.
a technology with huge consequences,
ovo je tehnoloija sa ogromnim posledicama,
moratorijuma ili karantina
or a moratorium or a quarantine
the therapeutic results of this,
terapijski rezultati ovoga,
gaining traction,
„Ekonomista“ - „Menjanje čovečanstva“.
of The Economist -- "Editing humanity."
ne o lečenjima.
it's not about therapeutics.
did you get back in March
i razmislimo na trenutak?
for a moment and think about it?
were actually, I think, delighted
u stvari bile oduševljene
otvoreno razgovaraju.
to discuss this openly.
dok razgovaram sa ljudima,
as well as others,
of viewpoints about this.
pažljivo razmotriti i o njoj pričati.
careful consideration and discussion.
veliki sastanak
happening in December
akademijom i drugima.
of Sciences and others,
tog sastanka, u praktičnom smislu?
out of the meeting, practically?
and stakeholders
this technology responsibly.
o odgovornom korišćenju ove tehnologije.
a consensus point of view,
na primer, sa Harvarda,
for example, at Harvard,
pitanja sigurnosti.
are just a question of safety.
na životinjama u laboratoriji,
in animals and in labs,
we move on to humans."
prelazimo na ljude.“
school of thought,
this opportunity and really go for it.
i prihvatimo je.
in the science community about this?
razdor u naučnoj zajednici?
da se neki uzdržavaju
some people holding back
ili nikakvu regulativu?
or don't regulate at all?
especially something like this,
novom tehnologijom, posebno ovakvom,
a variety of viewpoints,
perfectly understandable.
for human genome engineering,
za inženjering ljudskog genoma,
consideration and discussion
i razmatranja
and other fields of science
i druga naučna polja
skoro kao vaše polje.
pretty much like yours.
autonomne robote itd.
intelligence, autonomous robots and so on.
a similar discussion in those fields,
sličnu diskusiju u tim poljima,
serve as a blueprint for other fields?
poslužiti kao primer drugima?
da izađu iz laboratorije.
to get out of the laboratory.
uncomfortable to do that.
in the genesis of this
biti deo nastanka ovoga,
in a position of responsibility.
u poziciju odgovornosti.
that other technologies
da će ostale tehnologije
something that could have implications
što bi moglo imati posledice
ABOUT THE SPEAKER
Jennifer Doudna - BiologistJennifer Doudna was part of inventing a potentially world-changing genetic technology: the gene editing technology CRISPR-Cas9.
Why you should listen
Together with her colleague Emmanuelle Charpentier of Umeå University in Sweden, Berkeley biologist Jennifer Doudna is at the center of one of today's most-discussed science discoveries: a technology called CRISPR-Cas9 that allows human genome editing by adding or removing genetic material at will. This enables fighting genetic diseases (cutting out HIV, altering cancer cells) as well as, potentially, opening the road to "engineered humans."
Because some applications of genetic manipulation can be inherited, Doudna and numerous colleagues have called for prudent use of the technology until the ethics and safety have been properly considered.
Doudna is the co-winner of the 2018 Kavli Prize in Nanoscience, along with Emmanuelle Charpentier and Virginijus Šikšnys.
Jennifer Doudna | Speaker | TED.com